Sumitomo Life Insurance Co. Has $1.07 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Sumitomo Life Insurance Co. raised its holdings in Colgate-Palmolive (NYSE:CL) by 3.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,283 shares of the company’s stock after buying an additional 298 shares during the quarter. Sumitomo Life Insurance Co.’s holdings in Colgate-Palmolive were worth $1,067,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of CL. Diversify Advisory Services LLC acquired a new position in shares of Colgate-Palmolive during the 1st quarter valued at $911,000. TD Asset Management Inc raised its holdings in shares of Colgate-Palmolive by 2.4% during the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock valued at $103,969,000 after purchasing an additional 26,987 shares during the period. Empowered Funds LLC boosted its position in shares of Colgate-Palmolive by 277.3% during the 1st quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock worth $2,979,000 after purchasing an additional 24,314 shares in the last quarter. M&G Plc bought a new position in shares of Colgate-Palmolive during the 1st quarter worth about $3,812,000. Finally, Sei Investments Co. grew its stake in shares of Colgate-Palmolive by 41.5% in the 1st quarter. Sei Investments Co. now owns 598,639 shares of the company’s stock valued at $53,901,000 after buying an additional 175,445 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Down 0.3 %

NYSE CL opened at $101.20 on Thursday. The business’s fifty day moving average is $103.51 and its 200-day moving average is $97.44. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The stock has a market capitalization of $83.03 billion, a price-to-earnings ratio of 32.03, a PEG ratio of 3.54 and a beta of 0.40. Colgate-Palmolive has a one year low of $71.22 and a one year high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same quarter in the previous year, the firm posted $0.77 earnings per share. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.98%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Analysts Set New Price Targets

Several brokerages have issued reports on CL. Bank of America increased their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Citigroup increased their target price on Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. BNP Paribas assumed coverage on shares of Colgate-Palmolive in a report on Monday, June 24th. They set an “outperform” rating and a $109.00 price objective on the stock. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $106.00.

Insider Buying and Selling at Colgate-Palmolive

In related news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the sale, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 over the last ninety days. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.